BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lencioni R, Crocetti L. A Critical Appraisal of the Literature on Local Ablative Therapies for Hepatocellular Carcinoma. Clinics in Liver Disease 2005;9:301-14. [DOI: 10.1016/j.cld.2004.12.002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Sun CY, Zhu HT. Comprehensive surgical management of pancreatic cancer. Shijie Huaren Xiaohua Zazhi 2014; 22(2): 159-163 [DOI: 10.11569/wcjd.v22.i2.159] [Reference Citation Analysis]
2 Wallace MB, Sabbagh LC. EUS 2008 Working Group document: evaluation of EUS-guided tumor ablation. Gastrointest Endosc. 2009;69:S59-S63. [PMID: 19179172 DOI: 10.1016/j.gie.2008.11.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
3 Girelli R, Frigerio I, Giardino A, Regi P, Gobbo S, Malleo G, Salvia R, Bassi C. Results of 100 pancreatic radiofrequency ablations in the context of a multimodal strategy for stage III ductal adenocarcinoma. Langenbecks Arch Surg 2013;398:63-9. [DOI: 10.1007/s00423-012-1011-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
4 Maher MM, Hodnett PA, Kalra MK. Evidence-based Practice in Radiology: Steps 3 and 4—Appraise and Apply Interventional Radiology Literature. Radiology 2007;242:658-70. [DOI: 10.1148/radiol.2423060008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
5 Finn RS, Zhu AX. Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab. Expert Rev Anticancer Ther. 2009;9:503-509. [PMID: 19374603 DOI: 10.1586/era.09.6] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 5.4] [Reference Citation Analysis]
6 Kim JY, Kwon YH, Lee SJ, Jang SY, Yang HM, Jeon SW, Kweon YO. [Abscesso-colonic fistula following radiofrequency ablation therapy for hepatocellular carcinoma; a case successfully treated with histoacryl embolization]. Korean J Gastroenterol 2011;58:270-4. [PMID: 22113044 DOI: 10.4166/kjg.2011.58.5.270] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
7 Garrean S, Hering J, Helton WS, Espat NJ. A primer on transarterial, chemical, and thermal ablative therapies for hepatic tumors. Am J Surg 2007;194:79-88. [PMID: 17560915 DOI: 10.1016/j.amjsurg.2006.11.025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
8 Ballarin R, Spaggiari M, Cautero N, De Ruvo N, Montalti R, Longo C, Pecchi A, Giacobazzi P, De Marco G, D'Amico G, Gerunda GE, Di Benedetto F. Pancreatic metastases from renal cell carcinoma: the state of the art. World J Gastroenterol 2011;17:4747-56. [PMID: 22147975 DOI: 10.3748/wjg.v17.i43.4747] [Cited by in CrossRef: 95] [Cited by in F6Publishing: 82] [Article Influence: 8.6] [Reference Citation Analysis]
9 Lencioni R, Crocetti L. Image-guided thermal ablation of hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2008;66:200-7. [DOI: 10.1016/j.critrevonc.2008.01.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
10 Tsai W, Cheng J, Lai K, Lin C, Lo G, Hsu P, Yu H, Lin C, Chan H, Chen W, Chen T, Li W, Liang H. Clinical trial: percutaneous acetic acid injection vs. percutaneous ethanol injection for small hepatocellular carcinoma - a long-term follow-up study. Alimentary Pharmacology & Therapeutics 2008;28:304-11. [DOI: 10.1111/j.1365-2036.2008.03702.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
11 Vivanco M, Gabrielli M, Jarufe N, Humeres R, Rios H, Palacios JM, Zapata R, Sanhueza E, Contreras J, Rencore G, Rossi R, Martínez J, Pérez R, Guerra J, Arrese M, Figueroa E, Soza A, Yáñes R, Hepp J. Bridge therapy in hepatocellular carcinoma before liver transplantation: the experience of two Chilean centers. Transplant Proc 2010;42:296-8. [PMID: 20172335 DOI: 10.1016/j.transproceed.2009.11.019] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Galun D, Basaric D, Zuvela M, Bulajic P, Bogdanovic A, Bidzic N, Milicevic M. Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols. World J Hepatol 2015; 7(20): 2274-2291 [PMID: 26380652 DOI: 10.4254/wjh.v7.i20.2274] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
13 Lencioni R, Llovet JM. Percutaneous ethanol injection for hepatocellular carcinoma: alive or dead? J Hepatol. 2005;43:377-380. [PMID: 16005537 DOI: 10.1016/j.jhep.2005.06.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
14 Spangenberg HC, Mohr L, Blum HE. [Regional therapy of liver tumors]. Internist (Berl). 2007;48:40-45. [PMID: 17160664 DOI: 10.1007/s00108-006-1771-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Orgera G, Krokidis M, Monfardini L, Arnone P, Bonomo G, Della Vigna P, Curigliano G, Orsi F. Ultrasound-guided high-intensity focused ultrasound (USgHIFU) ablation in pancreatic metastasis from renal cell carcinoma. Cardiovasc Intervent Radiol 2012;35:1258-61. [PMID: 22011784 DOI: 10.1007/s00270-011-0291-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
16 Ma H, Liu J, Liu F. CT-guided single high-dose percutaneous acetic acid injection for small hepatocellular carcinoma: a long-term follow-up study. Eur J Radiol 2012;81:1184-6. [PMID: 21511422 DOI: 10.1016/j.ejrad.2011.03.063] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
17 McGrane S, McSweeney SE, Maher MM. Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic. Abdom Imaging. 2008;33:48-53. [PMID: 17874263 DOI: 10.1007/s00261-007-9313-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
18 Gish RG, Lencioni R, Di Bisceglie AM, Raoul J, Mazzaferro V. Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2014;6:173-85. [DOI: 10.1586/egh.11.105] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
19 Girelli R, Frigerio I, Salvia R, Barbi E, Tinazzi Martini P, Bassi C. Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer. Br J Surg. 2010;97:220-225. [PMID: 20069610 DOI: 10.1002/bjs.6800] [Cited by in Crossref: 114] [Cited by in F6Publishing: 109] [Article Influence: 9.5] [Reference Citation Analysis]
20 Zou YP, Li WM, Zheng F, Li FC, Huang H, Du JD, Liu HR. Intraoperative radiofrequency ablation combined with 125iodine seed implantation for unresectable pancreatic cancer. World J Gastroenterol 2010; 16(40): 5104-5110 [PMID: 20976848 DOI: 10.3748/wjg.v16.i40.5104] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
21 Gogia S, Befeler AS. Treating hepatocellular carcinoma without liver transplantation. Curr Gastroenterol Rep 2009;11:69-75. [PMID: 19166662 DOI: 10.1007/s11894-009-0011-9] [Reference Citation Analysis]
22 Finn RS. Drug therapy: sorafenib. Hepatology. 2010;51:1843-1849. [PMID: 20432260 DOI: 10.1002/hep.23676] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
23 Orgera G, Krokidis M, Monfardini L, Bonomo G, Della Vigna P, Fazio N, Orsi F. High intensity focused ultrasound ablation of pancreatic neuroendocrine tumours: report of two cases. Cardiovasc Intervent Radiol. 2011;34:419-423. [PMID: 20521049 DOI: 10.1007/s00270-010-9884-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
24 Lencioni R, Crocetti L. Radiofrequency Ablation of Liver Cancer. Techniques in Vascular and Interventional Radiology 2007;10:38-46. [DOI: 10.1053/j.tvir.2007.08.006] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
25 Dhanasekaran R, Limaye A, Cabrera R. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics. Hepat Med. 2012;4:19-37. [PMID: 24367230 DOI: 10.2147/hmer.s16316] [Cited by in Crossref: 39] [Cited by in F6Publishing: 132] [Article Influence: 3.9] [Reference Citation Analysis]
26 Crocetti L, Lencioni R. Thermal ablation of hepatocellular carcinoma. Cancer Imaging 2008;8:19-26. [PMID: 18331969 DOI: 10.1102/1470-7330.2008.0004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
27 Tam AL, Melancon MP, Abdelsalam M, Figueira TA, Dixon K, McWatters A, Zhou M, Huang Q, Mawlawi O, Dunner K Jr, Li C, Gupta S. Imaging Intratumoral Nanoparticle Uptake After Combining Nanoembolization with Various Ablative Therapies in Hepatic VX2 Rabbit Tumors. J Biomed Nanotechnol 2016;12:296-307. [PMID: 27305763 DOI: 10.1166/jbn.2016.2174] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
28 Smith MT, Ray CE. The treatment of primary and metastatic hepatic neoplasms using percutaneous cryotherapy. Semin Intervent Radiol. 2006;23:39-46. [PMID: 21326719 DOI: 10.1055/s-2006-939840] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
29 Tabrizian P, Roayaie S, Schwartz ME. Current management of hepatocellular carcinoma. World J Gastroenterol 2014; 20(30): 10223-10237 [PMID: 25132740 DOI: 10.3748/wjg.v20.i30.10223] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
30 Melancon MP, Appleton Figueira T, Fuentes DT, Tian L, Qiao Y, Gu J, Gagea M, Ensor JE, Muñoz NM, Maldonado KL, Dixon K, McWatters A, Mitchell J, McArthur M, Gupta S, Tam AL. Development of an Electroporation and Nanoparticle-based Therapeutic Platform for Bone Metastases. Radiology 2018;286:149-57. [PMID: 28825892 DOI: 10.1148/radiol.2017161721] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
31 Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee FT, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why? Radiographics. 2014;34:1344-1362. [PMID: 25208284 DOI: 10.1053/j.tvir.2007.08.005] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 8.9] [Reference Citation Analysis]
32 Cabrera R, Nelson DR. Review article: the management of hepatocellular carcinoma. Aliment Pharmacol Ther 2010;31:461-76. [PMID: 19925500 DOI: 10.1111/j.1365-2036.2009.04200.x] [Cited by in Crossref: 129] [Cited by in F6Publishing: 122] [Article Influence: 9.9] [Reference Citation Analysis]
33 Kim RD, Reed AI, Fujita S, Foley DP, Mekeel KL, Hemming AW. Consensus and controversy in the management of hepatocellular carcinoma. J Am Coll Surg. 2007;205:108-123. [PMID: 17617340 DOI: 10.1016/j.jamcollsurg.2007.02.025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
34 Lencioni R, Crocetti L, Pina MCD, Cioni D. Percutaneous image-guided radiofrequency ablation of liver tumors. Abdom Imaging 2009;34:547-56. [DOI: 10.1007/s00261-008-9479-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]